US drugmakers call for reversing Texas abortion pill ruling

Ardelyx

10/04/2023 16:44

April 10 (Reuters) - Over 300 biotech and pharmaceutical
industry executives, including Pfizer Inc  PFE.N  CEO Albert
Bourla, signed an open letter on Monday seeking the reversal of
a federal judge's decision to suspend sales of the abortion pill
mifepristone.
    A U.S. judge on Friday suspended the U.S. Food and Drug
Administration's two-decade-old approval of the drug,
effectively banning sales while a case brought by anti-abortion
groups before him continues in the Northern District of Texas.
    Last week's ruling by Judge Matthew Kacsmaryk undermines the
FDA's authority, the letter's authors wrote, adding that it
ignores decades of scientific evidence and legal precedent.

 (Reporting by Michael Erman in New York and Bhanvi Satija in
Bengaluru; Editing by Bill Berkrot)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))